{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:11:06Z","timestamp":1791288666899,"version":"4.3.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Research Reviews"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.brainresrev.2008.12.006","type":"journal-article","created":{"date-parts":[[2008,12,26]],"date-time":"2008-12-26T04:17:26Z","timestamp":1230265046000},"page":"267-277","source":"Crossref","is-referenced-by-count":301,"title":["Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks"],"prefix":"10.1016","volume":"60","author":[{"given":"Gilbert Y.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narender R.","family":"Gavva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresrev.2008.12.006_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1213\/ane.0b013e31816b94c9","article-title":"The effect of wound instillation of a novel purified capsaicin formulation on postherniotomy pain: a double-blind, randomized, placebo-controlled study","volume":"107","author":"Aasvang","year":"2008","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib2","series-title":"American Academy of Neurology 55th Annual Meeting","article-title":"A single one-hour application of high-concentration capsaicin patches leads to four weeks of pain relief in postherpetic neuralgia patients","author":"Backonja","year":"2003"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib3","series-title":"Society for Neuroscience Annual Meeting. Vol., ed.^eds","article-title":"Involvement of TRPV1 in the regulation of body temperature in rats and mice","author":"Bannon","year":"2004"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1476-5381.1992.tb12781.x","article-title":"Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin","volume":"107","author":"Bevan","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib5","first-page":"S39","article-title":"Safety, tolerability and efficacy of ALGRX 4975 in Osteoarthritis (OA) of the knee","volume":"6","author":"Cantillon","year":"2005","journal-title":"J. Pain Off. J. Am. Pain Soc."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib6","first-page":"S39","article-title":"Preliminary safety, tolerability and efficacy of ALGRX 4975 in osteoarthritis (OA) of the knee","volume":"6","author":"Cantillon","year":"2005","journal-title":"J. Pain Off. J. Am. Pain Soc."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib7","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.jpain.2005.01.190","article-title":"Safety, tolerability and efficacy of intraoperative ALGRX 4975 in a randomized, double-blind, placebo-controlled study of subjects undergoing bunionectomy","volume":"6","author":"Cantillon","year":"2005","journal-title":"J. Pain Off. J. Am. Pain Soc."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib8","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1152\/ajpregu.00446.2006","article-title":"Transient receptor potential ion channels as participants in thermosensation and thermoregulation","volume":"292","author":"Caterina","year":"2007","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib9","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00192-005-1307-4","article-title":"Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC)","volume":"16","author":"Chen","year":"2005","journal-title":"Int. Urogynecol. J. Pelvic Floor Dysfunct."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pain.2007.06.006","article-title":"The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans","volume":"132","author":"Chizh","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib13","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/j.1432-1033.2004.04082.x","article-title":"Biochemical pharmacology of the vanilloid receptor TRPV1. An update","volume":"271","author":"Cortright","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib14","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.1523\/JNEUROSCI.1246-06.2006","article-title":"TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists","volume":"26","author":"Cui","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1021\/jm051058x","article-title":"Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain","volume":"49","author":"Culshaw","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/35012076","article-title":"Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia","volume":"405","author":"Davis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib17","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jpain.2006.01.162","article-title":"(760): ALGRX 4975 reduces pain of intermetatarsal neuroma: preliminary results from a randomized, double-blind, placebo-controlled, phase II multicenter clinical trial","volume":"7","author":"Diamond","year":"2006","journal-title":"J. Pain Off. J. Am. Pain Soc."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1046\/j.1468-2982.2000.00088.x","article-title":"Intranasal civamide for the acute treatment of migraine headache","volume":"20","author":"Diamond","year":"2000","journal-title":"Cephalalgia"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib19","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1021\/jm070190p","article-title":"Novel vanilloid receptor-1 antagonists: 2. Structure\u2013activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate","volume":"50","author":"Doherty","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0014-2999(90)90091-J","article-title":"NE-19550 and NE-21610, antinociceptive capsaicin analogues: studies on nociceptive fibres of the neonatal rat tail in vitro","volume":"181","author":"Dray","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib21","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1124\/mol.105.015727","article-title":"Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1","volume":"68","author":"Gavva","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib22","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/jpet.104.079855","article-title":"AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties","volume":"313","author":"Gavva","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/jpet.107.125674","article-title":"Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade","volume":"323","author":"Gavva","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib24","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1523\/JNEUROSCI.4833-06.2007","article-title":"The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation","volume":"27","author":"Gavva","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib25","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pain.2008.01.024","article-title":"Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans","volume":"136","author":"Gavva","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib26","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1523\/JNEUROSCI.3815-04.2005","article-title":"Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain","volume":"25","author":"Ghilardi","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1021\/jm701007g","article-title":"Identification of (R)-1-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea (ABT-102) as a potent TRPV1 antagonist for pain management","volume":"51","author":"Gomtsyan","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/138161208783330754","article-title":"Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms","volume":"14","author":"Gunthorpe","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib29","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1124\/jpet.106.116657","article-title":"Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1\/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor","volume":"321","author":"Gunthorpe","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2004.07.028","article-title":"TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia","volume":"500","author":"Holzer","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.105.083915","article-title":"A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats","volume":"314","author":"Honore","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.semcdb.2006.09.004","article-title":"The TRPV1 receptor and nociception","volume":"17","author":"Immke","year":"2006","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejphar.2005.05.002","article-title":"Pharmacological characterization of the TRPV1 receptor antagonist JYL1421 (SC0030) in vitro and in vivo in the rat","volume":"517","author":"Jakab","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib34","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1021\/jm00070a002","article-title":"Vanilloids. 1. Analogs of capsaicin with antinociceptive and antiinflammatory activity","volume":"36","author":"Janusz","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0896-6273(02)00908-X","article-title":"p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia","volume":"36","author":"Ji","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib36","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1172\/JCI20449","article-title":"Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control","volume":"113","author":"Karai","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib37","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.21297","article-title":"Involvement of transient receptor potential vanilloid 1 in the vascular and hyperalgesic components of joint inflammation","volume":"52","author":"Keeble","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/AJP.0b013e318158ed9e","article-title":"Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?","volume":"24","author":"Knotkova","year":"2008","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib39","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1021\/jm030089u","article-title":"N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor","volume":"46","author":"Lee","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.107.132233","article-title":"Antihyperalgesic effects of AMG8562, a novel vanilloid receptor TRPV1 modulator that does not cause hyperthermia in rats","volume":"326","author":"Lehto","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib41","series-title":"International Association for the Study of Pain (IASP)","article-title":"Efficacy of a novel TRPV1 antagonist, AMG8163, in various rat models of pain","author":"Magal","year":"2005"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib42","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/sj.bjp.0703918","article-title":"Pharmacological differences between the human and rat vanilloid receptor 1 (VR1)","volume":"132","author":"McIntyre","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2005.09.046","article-title":"Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice","volume":"393","author":"Menendez","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib44","doi-asserted-by":"crossref","DOI":"10.1007\/s00192-008-0663-2","article-title":"Resiniferatoxin in the treatment of interstitial cystitis: a systematic review","author":"Mourtzoukou","year":"2008","journal-title":"Int. Urogynecol. J. Pelvic Floor Dysfunct."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib45","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1021\/jm060065y","article-title":"Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure\u2013activity relationships of 2-piperazin-1-yl-1H-benzimidazoles","volume":"49","author":"Ognyanov","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib46","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/01.ju.0000154631.92150.ef","article-title":"Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial","volume":"173","author":"Payne","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/jpet.102.046268","article-title":"N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine-1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. in vivo characterization in rat models of inflammatory and neuropathic pain","volume":"306","author":"Pomonis","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib48","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/j.bmcl.2006.03.030","article-title":"Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development","volume":"16","author":"Rami","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib49","first-page":"120","article-title":"Adlea (ALGRX-4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for longlasting pain relief","volume":"11","author":"Remadevi","year":"2008","journal-title":"IDrugs"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib50","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jpain.2006.01.416","article-title":"(312\/759): ALGRX 4975 reduces pain of acute lateral epicondylitis: preliminary results from a randomized, double-blind, placebo-controlled, phase II multicenter clinical trial","volume":"7","author":"Richards","year":"2006","journal-title":"J. Pain Off. J. Am. Pain Soc."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib51","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/archneur.59.6.990","article-title":"Intranasal civamide for the treatment of episodic cluster headaches","volume":"59","author":"Saper","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib52","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1212\/01.wnl.0000314647.35825.9c","article-title":"Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jpainsymman.2007.04.015","article-title":"An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy","volume":"35","author":"Simpson","year":"2008","journal-title":"J. Pain Symptom Manage"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib54","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1523\/JNEUROSCI.1483-07.2007","article-title":"Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors","volume":"27","author":"Steiner","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib55","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1124\/jpet.108.138511","article-title":"ABT-102 ((R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea) blocks polymodal activation of TRPV1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo","volume":"326","author":"Surowy","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib56","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1021\/jm0495071","article-title":"Identification and biological evaluation of 4-(3-Trifluoromethylpyridin-2-yl)piperazine-1-carboxylic Acid (5-Trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist","volume":"48","author":"Swanson","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF00168777","article-title":"[3H]resiniferatoxin binding by the vanilloid receptor: species-related differences, effects of temperature and sulfhydryl reagents","volume":"347","author":"Szallasi","year":"1993","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0031-6997(24)01403-0","article-title":"Vanilloid (Capsaicin) receptors and mechanisms","volume":"51","author":"Szallasi","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrd2280","article-title":"The vanilloid receptor TRPV1: 10\u00a0years from channel cloning to antagonist proof-of-concept","volume":"6","author":"Szallasi","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib60","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.npep.2004.07.005","article-title":"Forty years in capsaicin research for sensory pharmacology and physiology","volume":"38","author":"Szolcsanyi","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib61","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1021\/jm7014638","article-title":"Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists","volume":"51","author":"Tamayo","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib62","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0896-6273(00)80564-4","article-title":"The cloned capsaicin receptor integrates multiple pain-producing stimuli","volume":"21","author":"Tominaga","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3959(00)00349-3","article-title":"In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue","volume":"89","author":"Urban","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.brainresrev.2008.12.006_bib64","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.102.042010","article-title":"The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain","volume":"304","author":"Walker","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib65","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1021\/jm00068a015","article-title":"Analogues of capsaicin with agonist activity as novel analgesic agents; structure\u2013activity studies. 2. The amide bond \u201cB-region\u201d","volume":"36","author":"Walpole","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib66","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1021\/jm00068a016","article-title":"Analogues of capsaicin with agonist activity as novel analgesic agents; structure\u2013activity studies. 3. The hydrophobic side-chain \u201cC-region\u201d","volume":"36","author":"Walpole","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib67","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/jm00068a014","article-title":"Analogues of capsaicin with agonist activity as novel analgesic agents; structure\u2013activity studies. 1. The aromatic \u201cA-region\u201d","volume":"36","author":"Walpole","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainresrev.2008.12.006_bib68","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1021\/jm960512h","article-title":"Analogues of capsaicin with agonist activity as novel analgesic agents: structure\u2013activity studies. 4. Potent, orally active analgesics","volume":"39","author":"Wrigglesworth","year":"1996","journal-title":"J. Med. Chem."}],"container-title":["Brain Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165017308001446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165017308001446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T06:43:41Z","timestamp":1738824221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165017308001446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0165017308001446"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresrev.2008.12.006","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1160292.619626","asserted-by":"object"}]},"ISSN":["0165-0173"],"issn-type":[{"value":"0165-0173","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}